𝔖 Bobbio Scriptorium

✦ LIBER ✦

A Phase II Trial of Humanized Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Androgen-Independent Prostate Cancer

✍ Scribed by David M. Reese; Paige Fratesi; Michelle Corry; William Novotny; Eric Holmgren; Eric J. Small

Book ID: 114436366
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 176 KB
Volume: 3
Category: Article
ISSN: 1095-5100
DOI: 10.1046/j.1525-1411.2001.32007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Randomized Double-Masked Tria

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 427 KB

A Tomato-Based, Lycopene-Containing Inte

A Tomato-Based, Lycopene-Containing Intervention for Androgen-Independent Prostate Cancer: Results of a Phase II Study from The North Central Cancer Treatment Group

✍ Aminah Jatoi; Patrick Burch; David Hillman; Joanne M. Vanyo; Shaker Dakhil; Dani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Tanezumab, an Anti-Nerve Growth Factor (

Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial

✍ N. Katz; D. Borenstein; C. Birbara; C. Bramson; M. Nemeth; M. Smith; M. Brown 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

647 POSTER A phase I dose-escalation stu

647 POSTER A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase II trial of green tea in the tre

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ, Mayo Clinic and Mayo Foundation, Rochester, MN: Cancer 2003;97:1442–1446

✍ Donald L Trump 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 22 KB

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer: Mathew P, Thall PF, Jones D, Perez C, Bucana C, Troncoso P, Kim SJ, Fidler IJ, Logothetis C., Department of Genitourinary Medical Oncology, Unit 427, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX. J Clin Oncol 2004;22:3323–9

✍ Gurkamal Chatta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB